Global Facial Cleanser Market Size Likely to Surpass at a CAGR of 5.80% By 2033

As per the current market research conducted by the CMI Team, the global Facial Cleanser Market size is expected to record a CAGR of 5.80% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 13,860 Million. By 2033, the valuation is anticipated to reach USD 23,020 Million.

Facial Cleanser Market: Growth Factors and Dynamics

• Product Innovation and Diversity: Skincare companies continually innovate to introduce new formulations, ingredients, and technologies in facial cleansers. This includes products tailored to different skin types (e.g., oily, dry, sensitive), concerns (e.g., acne, aging), and preferences (e.g., natural ingredients, vegan products).

• Rising Disposable Income and Urbanization: Economic growth in many regions has led to increased disposable income, especially among urban populations. This demographic is more likely to spend on personal care products, including facial cleansers.

• Changing Lifestyles and Consumer Behaviour: Busy lifestyles and urban living often lead to higher stress levels and exposure to pollutants, which drive the demand for effective skincare products like facial cleansers.

• E-commerce and Online Retail: The ease of purchasing skincare products online has significantly boosted market accessibility. Consumers can research products, read reviews, and make purchases conveniently, leading to a wider reach and sales growth.

• Health and Wellness Trends: The trend towards overall health and wellness, including self-care routines, has contributed to the growth of the facial cleanser market. Consumers view skincare as an essential part of their wellness regimen.

• Men’s Grooming Market: The increasing acceptance and growth of the men’s grooming market, including facial cleansing products tailored for men, have expanded the overall market size.

Facial Cleanser Market: Product development

• In April 2024, QIAGEN N.V. announced new products to enhance cancer research and enable urine collection for liquid biopsy. These innovations, along with the upcoming IVD version of the QIAcuity digital PCR platform, will debut at the AACR annual meeting in San Diego, April 5-10. The event will feature two Exhibitor Spotlight Theater sessions and several poster presentations showcasing QIAGEN’s advancements in cancer research.

• In April 2024, Bio-Rad Laboratories, Inc. unveiled its pioneering ddPLEX ESR1 Mutation Detection Kit, marking its foray into ultrasensitive multiplexed digital PCR assays. Catering to the oncology sector, this innovation enhances the company’s Droplet Digital PCR (ddPCR™) lineup. The kit’s high sensitivity and multiplexed capabilities promise to revolutionize translational research, therapy selection, and disease tracking in oncology. As Bio-Rad continues to innovate in life science and clinical diagnostics, this launch signifies a significant advancement in precision medicine.

• In May 2023, BD (Becton, Dickinson and Company) launched a groundbreaking cell sorting instrument featuring BD CellView™ Image and BD SpectralFX™ Technologies. BD CellView™ allows researchers to see detailed microscopic images and sort cells at high speeds based on visual traits. BD SpectralFX™ enables full-spectrum cell sorting with a simplified workflow. This new BD FACSDiscover™ S8 Cell Sorter enhances research capabilities, promising advancements in drug discovery, immuno-oncology, and genomics.

• In March 2022, Mission Bio, Inc. introduced the Tapestri Solution for Solid Tumor Research. This comprehensive single-cell DNA sequencing workflow on the Tapestri Platform features a nuclei isolation prep protocol, pre-designed research panels for breast cancer and glioblastoma multiforme, and an enhanced single-cell copy number variation (CNV) bioinformatic analysis tool.

• In April 2022, 10x Genomics launched two new products: Fixed RNA Profiling and Nuclei Isolation Kits. These tools enhance sample preparation workflows and expand the use of the Chromium platform for single cell analysis. They facilitate multiomic analysis of fragile human tissues and improve accessibility to frozen sample analysis, which is typically costly and time-consuming. These innovations aim to advance research and human health by simplifying and broadening single cell analysis capabilities.

Report Scope

Facial Cleanser Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Facial Cleanser Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Supply Chain Disruptions: The facial cleanser market, like many others, experienced disruptions in the supply chain due to factory closures, transportation delays, and raw material shortages during the pandemic. This affected production and distribution.

• Decreased Disposable Income: Economic uncertainty and job losses have constrained consumer spending in many regions. This has led some consumers to reduce discretionary spending on non-essential items like premium facial cleansers.

• Impact on Physical Retail: Brick-and-mortar stores faced reduced foot traffic and temporary closures due to lockdown measures, impacting sales of facial cleansers traditionally sold in stores. Some retailers struggled to adapt to the shift towards online shopping.

• Shift in Consumer Priorities: While hygiene awareness increased, some consumers prioritized essential products over skincare items, especially during the initial phases of the pandemic. This shift affected sales and marketing strategies in the facial cleanser market.

• Increased Hygiene Awareness: The pandemic has heightened awareness about personal hygiene, including facial cleansing routines. This has driven demand for facial cleansers as consumers prioritize cleanliness.

• Shift Towards Skincare: With more people staying at home and focusing on self-care routines, there has been a notable shift towards skincare products, including facial cleansers. Consumers are willing to invest in products that promote healthy skin.

• E-commerce Growth: Lockdowns and restrictions on physical retail spaces have accelerated the growth of online shopping. Many consumers have turned to e-commerce platforms to purchase facial cleansers, leading to increased digital sales for brands.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Facial Cleanser Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Facial Cleanser Market:

• Amorepacific Corporation
• Avon Products Inc.
• Beiersdorf AG
• Coty Inc.
• Estée Lauder Companies
• Johnson & Johnson
• Kao Corporation
• L’Oréal
• Mary Kay Inc.
• Neutrogena Corporation
• Olay
• Procter & Gamble
• Shiseido Company
• The Body Shop International Limited
• Unilever
• Others

The Facial Cleanser Market is segmented as follows:

By Skin Type

• Normal Skin
• Oily skin
• Dry skin
• Sensitive skin
• Combination skin
• Others

By Product Type

• Gel cleanser
• Cream & lotion cleanser
• Foaming cleanser
• Bar cleanser
• Others

By Consumer Group

• Male
• Female
• Unisex

By End-use

• Individual
• Commercial

By Distribution Channel

• Online
• Offline

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America